CYTOPATHOS
Provides cytology, biopsy and molecular diagnostic testing for clinics and hospitals in Slovakia
Highlights
- ProfitableFY2025 net profit €443k · RÚZ
About CYTOPATHOS
CYTOPATHOS operates a laboratory providing cytology, biopsy and histology, immunohistochemistry, serum autoantibody screening, and molecular genetic testing. Its services include diagnostics related to tumors, genetic disorders, infections and autoimmune diseases.
Customers include surgical, dermatology, gastroenterology, ENT and gynecology practices, as well as hospitals. It provides testing services to healthcare providers and also lists services for self-paying patients.
The company is based in Bratislava and was founded in 2004. Its laboratory is accredited by the Slovak National Accreditation Service under ISO 15189:2012; it states that it began using Hologic's Genius Digital Diagnostics System for cervical cancer screening in January 2025.
Product: Laboratory diagnostic testing in cytology, histology, immunohistochemistry, autoantibody screening and molecular genetics.
Financials
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | €11.0M | €10.1M | €9.6M | €11.9M | €13.4M |
| Growth | +9% | +5% | −19% | −11% | — |
| EBITDA | €757k | €739k | €981k | €1.3M | €1.8M |
| Operating profit | €601k | €587k | €849k | €1.2M | €1.7M |
| Net profit | €443k | €498k | €670k | €925k | €1.3M |
| Net margin | 4% | 4.9% | 7% | 7.8% | 9.9% |
| Personnel costs | €5.5M | €4.9M | €4.6M | €4.6M | €6.5M |
| Total assets | €4.1M | €4.2M | €5.4M | €5.2M | €6.6M |
| Cash | €1.9M | €2.1M | €2.8M | €3.1M | €4.1M |
| Liabilities | €2.7M | €2.1M | €2.1M | €2.7M | €5.2M |
| Equity | €948k | €2.1M | €2.9M | €2.3M | €1.3M |
As filed with RÚZ (Slovak register of financial statements). Each year links to its statement.
Public contracts
Contracts CYTOPATHOS signed since 1 Nov 2024, from the Slovak and Czech public contract registers. Values as published; amendments are not counted.
Customers
6 contracts with 4 buyers · —
| Contracts | Value | |
|---|---|---|
| Všeobecná zdravotná poisťovňa, a. s. | 3 | — |
| Národný onkologický ústav | 1 | — |
| Ústredná Vojenská Nemocnica SNP Ružomberok - Fakultná Nemocnica | 1 | — |
Open public tenders for CYTOPATHOS →
Suppliers
2 contracts with 2 suppliers · €423k
| Contracts | Value | |
|---|---|---|
| Ministerstvo zdravotníctva SR | 1 | €378k |
| Kompetenčné a certifikačné centrum kybernetickej bezpečnosti | 1 | €45k |
Latest contracts
- 22 May 2026 for Ústredná Vojenská Nemocnica SNP Ružomberok - Fakultná Nemocnica · Zmluva o zabezpečení laboratórnej diagnostiky register
- 14 Oct 2025 for Národný onkologický ústav · Dohoda o vzájomnom započítaní pohľadávok č. 209/2025/NOU register
- 28 Aug 2025 for Všeobecná zdravotná poisťovňa, a. s. · Poskytovanie a úhrada zdravotnej starostlivosti a služieb súvisiacich s poskytovaním zdravotnej starostlivosti register
- 5 Mar 2025 from Ministerstvo zdravotníctva SR · Zmluva o poskytnutí prostriedkov mechanizmu na podporu obnovy a odolnosti č. 707/2024 · €378k register
- 26 Feb 2025 for Všeobecná zdravotná poisťovňa, a. s. · Poskytovanie a úhrada zdravotnej starostlivosti a služieb súvisiacich s poskytovaním zdravotnej starostlivosti register
- 18 Dec 2024 for Všeobecná zdravotná poisťovňa, a. s. · Poskytovanie a úhrada zdravotnej starostlivosti a služieb súvisiacich s poskytovaním zdravotnej starostlivosti register
Jobs at CYTOPATHOS
Leadership
- Marta Herzánová · Konateľ (Managing director)Source: business register
- Pavol Gomolčák · Konateľ (Managing director)Source: business register
More health & medtech companies
DaDent
Dental clinic in Piešťany offering implantology, oral surgery, prosthetics and preventive dentistry for patientsYoung companyGrowingDaneTax
Psychology, psychodiagnostics, therapy and home nursing services for individuals and patients in Bratislava and TrnavaProfitableGrowingDantistmed
Dental clinic in Voderady offering preventive, restorative, endodontic, prosthetic and oral surgery careYoung companyProfitableDanubia Clinic
Private orthopaedic and regenerative clinic in Bratislava treating joint, tendon and back pain, plus aesthetic injection treatmentsYoung companyDAPTI
General medical care and preventive services for patients at clinics in Stará Ľubovňa and Nová ĽubovňaProfitableNew on EvolcDark Therapy
Psychological consultations, career guidance and workshops for individuals, schools and organizationsYoung companyProfitableGrowing
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Backend
- PHPMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Cookie namedistinctive cookie name
- Cookie namedistinctive cookie name
- Cookie namedistinctive cookie name
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Monitoring
- New RelicMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
Privacy & consent
- CookiebotHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
